Company profile for Paratek Pharmaceuticals

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

At Paratek, solutions are provided that enable positive outcomes and lead to positive patient stories. Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments.We focus on drugs that target infectious disease and other difficult to treat conditions.Today, we have a particularly promisi...
At Paratek, solutions are provided that enable positive outcomes and lead to positive patient stories. Paratek Pharmaceuticals is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments.We focus on drugs that target infectious disease and other difficult to treat conditions.Today, we have a particularly promising antibiotic called Omadacycline for serious community acquired infections where resistance is of concern.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
75 Park Plaza 4th Floor Boston, MA 02116
Telephone
Telephone
617-807-6600
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/10/17/3168554/0/en/Paratek-Pharmaceuticals-to-Present-New-Data-on-NUZYRA-omadacycline-at-IDWeek-2025-and-CHEST-2025.html

GLOBENEWSWIRE
17 Oct 2025

https://www.globenewswire.com/news-release/2025/05/21/3085707/0/en/Paratek-Pharmaceuticals-Completes-Acquisition-of-Optinose-Creating-an-Expanded-Portfolio-of-Specialty-Therapies.html

GLOBENEWSWIRE
21 May 2025

https://www.globenewswire.com/news-release/2025/05/16/3083010/0/en/Paratek-Pharmaceuticals-to-Present-Clinical-Data-on-NUZYRA-omadacycline-at-the-American-Thoracic-Society-ATS-2025-International-Conference.html

GLOBENEWSWIRE
16 May 2025

https://www.globenewswire.com/news-release/2025/04/10/3059143/0/en/Paratek-Pharmaceuticals-to-Present-New-Data-on-NUZYRA-omadacycline-at-ESCMID-Global-2025.html

GLOBENEWSWIRE
10 Apr 2025

https://www.fiercepharma.com/pharma/paratek-acquires-optinose-and-rhinosinusitis-spray-xhance-330m

FIERCE PHARMA
21 Mar 2025

https://www.expresspharma.in/paratek-phase-iib-data-shows-omadacyclines-potential-to-address-unmet-needs-in-ntm-treatment-says-globaldata/

EXPRESSPHARMA
15 Nov 2024

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty